Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 59,30
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 70,23
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 66,75
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Chiron Media, Wallingford, Regno Unito
EUR 62,92
Quantità: 10 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 65,88
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 73,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 100.
Da: Revaluation Books, Exeter, Regno Unito
EUR 90,64
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 100 pages. 9.25x6.10x0.35 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 109,93
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 89 pages. 9.00x6.00x0.25 inches. In Stock.
Da: preigu, Osnabrück, Germania
EUR 59,30
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Dose-Finding Designs for Early-Phase Cancer Clinical Trials | A Brief Guidebook to Theory and Practice | Takashi Daimon (u. a.) | Taschenbuch | SpringerBriefs in Statistics | xv | Englisch | 2019 | Springer | EAN 9784431555841 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 69,27
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This bookalso covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs with covariates and drug combinations, maximum tolerated dose-schedule finding designs, and so on.
Editore: Geijutsu shinbun-sha, 1990
Da: Sunny Day Bookstore, SINGAPORE, Singapore
EUR 53,39
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Fine. Number of books: 1.
Editore: Geijutsu shinbun-sha, 1990
Da: Sunny Day Bookstore, SINGAPORE, Singapore
EUR 53,39
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Fine. Number of books: 1.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 54,23
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 64,19
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This bookalso covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs with covariates and drug combinations, maximum tolerated dose-schedule finding designs, and so on. 152 pp. Englisch.
Da: Majestic Books, Hounslow, Regno Unito
EUR 90,65
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 100.
Da: Majestic Books, Hounslow, Regno Unito
EUR 91,44
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 100.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 90,64
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 100.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 91,32
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 100.
Da: moluna, Greven, Germania
EUR 57,15
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Serves as an excellent resource in the design and analysis of early phase dose-finding trialsCovers a wide range of various methods for designing early phase dose-finding clinical trials in oncology and other areasProvides an overview o.
Da: moluna, Greven, Germania
EUR 57,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloKartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Focuses on the two advanced areas of adaptive model-based dose-finding methods for phase I trials with multiple drugs/outcomes in oncology and other fieldsProvides software implementations to facilitate planning of phase I trials using these metho.
Lingua: Inglese
Editore: Springer, Springer Mai 2019, 2019
ISBN 10: 4431555846 ISBN 13: 9784431555841
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 64,19
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This bookalso covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs with covariates and drug combinations, maximum tolerated dose-schedule finding designs, and so on.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 152 pp. Englisch.